Literature DB >> 23721515

Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma.

V Martini1, A Poggi2, F Riondato2, M E Gelain3, L Aresu3, S Comazzi1.   

Abstract

Histopathology and immunohistochemistry are mandatory to solve the differential between canine low-grade lymphoma and reactive hyperplasia. However, clinicians and owners often show reluctance toward these invasive tests. However, molecular biology techniques are still not sensitive and specific enough to be regarded as a reliable tool for final diagnosis. In humans, flow cytometry (FC) allows a definitive diagnosis of T-cell lymphoma based on high prevalence of antigen aberrancies. We describe here the immunophenotype of 26 cases of suspect canine small-clear cell lymphoma, determined by multi-colour FC. All cases showed antigen aberrancies and therefore neoplasia was always confirmed. As a consequence, we argue that the combined use of cytology and FC allows solving the differential diagnosis between small clear cell lymphoma and non-neoplastic reactive conditions when histopathology is not available. Further studies are needed to establish if any aberrancy can be considered indicative of specific histotypes.
© 2013 Blackwell Publishing Ltd.

Entities:  

Keywords:  aberrancies; diagnosis; flow cytometry; lymphoma; small clear cell

Mesh:

Year:  2013        PMID: 23721515     DOI: 10.1111/vco.12043

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  9 in total

1.  Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics.

Authors:  D M Seelig; P Avery; T Webb; J Yoshimoto; J Bromberek; E J Ehrhart; A C Avery
Journal:  J Vet Intern Med       Date:  2014-03-21       Impact factor: 3.333

Review 2.  Flow Cytometry in the Diagnosis of Canine T-Cell Lymphoma.

Authors:  Stefano Comazzi; Fulvio Riondato
Journal:  Front Vet Sci       Date:  2021-04-21

3.  Hematological and biochemical profiles of canine CD45- T lymphomas are different from other immunophenotypes.

Authors:  Rosina Sánchez-Solé; Florencia Mosquillo; Paulo Jark; Martín Breijo; Paula Pessina
Journal:  Open Vet J       Date:  2021-12-21

4.  Performance of lymph node cytopathology in diagnosis and characterization of lymphoma in dogs.

Authors:  Valeria Martini; Giuseppe Marano; Luca Aresu; Ugo Bonfanti; Patrizia Boracchi; Mario Caniatti; Francesco Cian; Matteo Gambini; Laura Marconato; Carlo Masserdotti; Arturo Nicoletti; Fulvio Riondato; Paola Roccabianca; Damiano Stefanello; Erik Teske; Stefano Comazzi
Journal:  J Vet Intern Med       Date:  2021-11-27       Impact factor: 3.333

5.  Clinical and Clinical Pathological Presentation of 310 Dogs Affected by Lymphoma with Aberrant Antigen Expression Identified via Flow Cytometry.

Authors:  Elena Celant; Laura Marconato; Damiano Stefanello; Pierangelo Moretti; Luca Aresu; Stefano Comazzi; Valeria Martini
Journal:  Vet Sci       Date:  2022-04-13

6.  Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases.

Authors:  P R Avery; J Burton; J L Bromberek; D M Seelig; R Elmslie; S Correa; E J Ehrhart; P S Morley; A C Avery
Journal:  J Vet Intern Med       Date:  2014-02-03       Impact factor: 3.333

Review 7.  Transformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality?

Authors:  Stefano Comazzi; Luca Aresu; Laura Marconato
Journal:  Front Vet Sci       Date:  2015-10-07

8.  The Comparative Diagnostic Features of Canine and Human Lymphoma.

Authors:  Davis M Seelig; Anne C Avery; E J Ehrhart; Michael A Linden
Journal:  Vet Sci       Date:  2016-06-09

9.  Breed-associated risks for developing canine lymphoma differ among countries: an European canine lymphoma network study.

Authors:  Stefano Comazzi; Stefano Marelli; Marzia Cozzi; Rita Rizzi; Riccardo Finotello; Joaquim Henriques; Josep Pastor; Frederique Ponce; Carla Rohrer-Bley; Barbara C Rütgen; Erik Teske
Journal:  BMC Vet Res       Date:  2018-08-06       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.